TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details






Profile for Gary Jean, Pharm.D., BCOP

Gary Jean

Gary Jean, Pharm.D., BCOP

  • Assistant Professor Pharmacy Practice Dal
Office Phone: 214-654-9404 ext 239
Email: gary.w.jean@ttuhsc.edu
Mail Address: 5920 Forest Park Rd Ste 400
Dallas TX 75235-6418

Biography

Gary Jean, Pharm.D., BCOP is an Assistant Professor in the Department of Pharmacy Practice at Texas Tech University Health Sciences Center School of Pharmacy. He received his Pharm.D. from the Texas Tech University Health Sciences Center School of Pharmacy, and completed a Pharmacy Practice Residency at the North Texas VA Medical Center and Specialty Residency in Hematology/Oncology at the North Texas VA Medical Center in conjunction with TTUHSC-SOP. His practice specialty is hematology/oncology. Dr. Jean's research interests include pharmacoeconomic, access to care in indigent populations, and supportive/palliative care.

Research Interests

Dr. Jean's scholarship interests include pharmacoeconomic, access to care in indigent populations, and supportive/palliative care

Selected Publications:

  • Devarakonda SS, Shahan JL, Takalkar A, Chaudhery SI, Jean G, Koshy NV, Heldebrandt GC. Graft-versus-lymphoma effect plus vorinostat as successful approach in a case of refractory gastric peripheral T cell lymphoma, not otherwise specified, after reduced intensity conditioning allogeneic hematopoietic cell transplant. Leukemia & Lymphoma. 2013;54(11):2545-7.
  • Shah SR, Jean G, Keisner SV, Ussery SG, Dowell JE. Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid. Supportive Care in Cancer. 2012;20(1):87-93.
  • Keisner SV, Shah SR, Jean G, Ussery SM, Dowell JE. Retrospective analysis of consequences of acid suppressive therapy on ketoconazole efficacy in advanced castration-resistant prostate cancer. Annals of Pharmacotherapy. 2010;44(10):1538-44.
  • Jean G, Shah SR. Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer. Pharmacotherapy. 2008;28(6):742-54.
©